암용 이중특이성항체 시장은 2024년부터 2029년까지 3억 3,800만 달러 증가하고, 예측 기간 동안 6.9%의 CAGR로 성장할 것으로 예상됩니다.
암용 이중특이성항체 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 시장은 암 유병률 증가, 단클론항체에 비해 이특이성 항체의 우월성, 이특이성 항체의 강력한 파이프라인에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준 연도 |
2025년 |
| 종료 연도 |
2029년 |
| 예측 기간 |
2025-2029년 |
| 성장 모멘텀 |
가속 |
| 전년 대비 2025년 |
6.4% |
| CAGR |
6.9% |
| 증가액 |
3억 3,800만 달러 |
이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.
본 보고서는 향후 수년간 암용 이중특이성항체 시장의 성장을 촉진하는 주요 요인 중 하나로 새로운 이중특이성항체 제작 플랫폼을 꼽고 있습니다. 또한, 전략적 제휴의 증가와 병용요법의 출현은 시장의 큰 수요로 이어질 것입니다.
목차
제1장 주요 요약
제2장 Technavio에 의한 분석
- 가격·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 상황
제4장 시장 규모
- 시장 정의
- 시장 부문 분석
- 시장 규모 2024년
- 시장 전망 2024-2029년
제5장 시장 규모 실적
- 암용 이중특이성항체 세계 시장 2019-2023년
- 유형별 부문 분석 2019-2023년
- 유통 채널별 부문 분석 2019-2023년
- 액션 메커니즘별 부문 분석 2019-2023년
- 치료 분야별 부문 분석 2019-2023년
- 지역별 부문 분석 2019-2023년
- 국가별 부문 분석 2019-2023년
제6장 정성 분석
- AI의 영향 : 암용 이중특이성항체 세계 시장
제7장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제8장 시장 세분화 : 유형별
- 시장 부문
- 비교 : 유형별
- CD19 또는 CD3 : 시장 규모와 예측 2024-2029년
- CD30 또는 CD16A : 시장 규모와 예측 2024-2029년
- 시장 기회 : 유형별
제9장 시장 세분화 : 유통 채널별
- 시장 부문
- 비교 : 유통 채널별
- 병원 : 시장 규모와 예측 2024-2029년
- 소매 약국 : 시장 규모와 예측 2024-2029년
- 온라인 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 유통 채널별
제10장 시장 세분화 : 액션 메커니즘별
- 시장 부문
- 비교 : 액션 메커니즘별
- 이중 항원 표적 : 시장 규모와 예측 2024-2029년
- 이중 차단 항체 : 시장 규모와 예측 2024-2029년
- T세포 인게이저 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 액션 메커니즘별
제11장 시장 세분화 : 치료 분야별
- 시장 부문
- 비교 : 치료 분야별
- 종양학 : 시장 규모와 예측 2024-2029년
- 자가면역질환 : 시장 규모와 예측 2024-2029년
- 감염증 : 시장 규모와 예측 2024-2029년
- 신경질환 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 치료 분야별
제12장 고객 상황
제13장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2024-2029년
- 유럽 : 시장 규모와 예측 2024-2029년
- 아시아 : 시장 규모와 예측 2024-2029년
- 세계 기타 지역 : 시장 규모와 예측 2024-2029년
- 미국 : 시장 규모와 예측 2024-2029년
- 아일랜드 : 시장 규모와 예측 2024-2029년
- 캐나다 : 시장 규모와 예측 2024-2029년
- 인도 : 시장 규모와 예측 2024-2029년
- 중국 : 시장 규모와 예측 2024-2029년
- 헝가리 : 시장 규모와 예측 2024-2029년
- 독일 : 시장 규모와 예측 2024-2029년
- 일본 : 시장 규모와 예측 2024-2029년
- 영국 : 시장 규모와 예측 2024-2029년
- 브라질 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 지역 상황별
제14장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회·억제요인
제15장 경쟁 구도
제16장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- ABL Bio Inc.
- AFFIMED N.V.
- Akeso Inc.
- Amgen Inc.
- Aptevo Therapeutics Inc.
- Astellas Pharma Inc.
- Chugai Pharmaceutical Co. Ltd.
- Eli Lilly and Co.
- EPIMAB BIOTHERAPEUTICS INC.
- F STAR THERAPEUTICS INC.
- F. Hoffmann La Roche Ltd.
- Glenmark Pharmaceuticals Ltd.
- Johnson and Johnson Services Inc.
- Mereo BioPharma Group Plc
- Merus N.V.
제17장 부록
ksm
The bispecific antibodies for cancer market is forecasted to grow by USD 338 million during 2024-2029, accelerating at a CAGR of 6.9% during the forecast period. The report on the bispecific antibodies for cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer, advantages of bispecific antibodies over monoclonal antibodies, and strong pipeline of bispecific antibodies.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 6.4% |
| CAGR | 6.9% |
| Incremental Value | $338 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's bispecific antibodies for cancer market is segmented as below:
By Type
- CD19 or CD3
- CD30 or CD16A
By Distribution Channel
- Hospitals
- Retail pharmacies
- Online
By Action Mechanism
- Dual antigen targeting
- Dual-blocking antibodies
- T-cell engagers
By Therapeutic Area
- Oncology
- Autoimmune diseases
- Infectious diseases
- Neurological disorders
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the emerging bispecific antibody generation platforms as one of the prime reasons driving the bispecific antibodies for cancer market growth during the next few years. Also, increase in strategic alliances and emergence of combination therapy will lead to sizable demand in the market.
The report on the bispecific antibodies for cancer market covers the following areas:
- Bispecific Antibodies For Cancer Market sizing
- Bispecific Antibodies For Cancer Market forecast
- Bispecific Antibodies For Cancer Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bispecific antibodies for cancer market vendors that include ABL Bio Inc., AFFIMED N.V., Akeso Inc., Amgen Inc., Aptevo Therapeutics Inc., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., Eli Lilly and Co., EPIMAB BIOTHERAPEUTICS INC., F STAR THERAPEUTICS INC., F. Hoffmann La Roche Ltd., Glenmark Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Mereo BioPharma Group PLC, Merus N.V., Pfizer Inc., Regeneron Pharmaceuticals Inc., TG Therapeutics Inc., Xencor Inc., and Y mAbs Therapeutics Inc.. Also, the bispecific antibodies for cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Action Mechanism
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Bispecific Antibodies For Cancer Market 2019 - 2023
- Historic Market Size - Data Table on Global Bispecific Antibodies For Cancer Market 2019 - 2023 ($ million)
- 5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
- 5.4 Action Mechanism segment analysis 2019 - 2023
- Historic Market Size - Action Mechanism Segment 2019 - 2023 ($ million)
- 5.5 Therapeutic Area segment analysis 2019 - 2023
- Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
- 5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Bispecific Antibodies for Cancer Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 CD19 or CD3 - Market size and forecast 2024-2029
- Chart on CD19 or CD3 - Market size and forecast 2024-2029 ($ million)
- Data Table on CD19 or CD3 - Market size and forecast 2024-2029 ($ million)
- Chart on CD19 or CD3 - Year-over-year growth 2024-2029 (%)
- Data Table on CD19 or CD3 - Year-over-year growth 2024-2029 (%)
- 8.4 CD30 or CD16A - Market size and forecast 2024-2029
- Chart on CD30 or CD16A - Market size and forecast 2024-2029 ($ million)
- Data Table on CD30 or CD16A - Market size and forecast 2024-2029 ($ million)
- Chart on CD30 or CD16A - Year-over-year growth 2024-2029 (%)
- Data Table on CD30 or CD16A - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Distribution Channel
- 9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
- 9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 9.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
- 9.4 Retail pharmacies - Market size and forecast 2024-2029
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- 9.5 Online - Market size and forecast 2024-2029
- Chart on Online - Market size and forecast 2024-2029 ($ million)
- Data Table on Online - Market size and forecast 2024-2029 ($ million)
- Chart on Online - Year-over-year growth 2024-2029 (%)
- Data Table on Online - Year-over-year growth 2024-2029 (%)
- 9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Action Mechanism
- 10.1 Market segments
- Chart on Action Mechanism - Market share 2024-2029 (%)
- Data Table on Action Mechanism - Market share 2024-2029 (%)
- 10.2 Comparison by Action Mechanism
- Chart on Comparison by Action Mechanism
- Data Table on Comparison by Action Mechanism
- 10.3 Dual antigen targeting - Market size and forecast 2024-2029
- Chart on Dual antigen targeting - Market size and forecast 2024-2029 ($ million)
- Data Table on Dual antigen targeting - Market size and forecast 2024-2029 ($ million)
- Chart on Dual antigen targeting - Year-over-year growth 2024-2029 (%)
- Data Table on Dual antigen targeting - Year-over-year growth 2024-2029 (%)
- 10.4 Dual-blocking antibodies - Market size and forecast 2024-2029
- Chart on Dual-blocking antibodies - Market size and forecast 2024-2029 ($ million)
- Data Table on Dual-blocking antibodies - Market size and forecast 2024-2029 ($ million)
- Chart on Dual-blocking antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Dual-blocking antibodies - Year-over-year growth 2024-2029 (%)
- 10.5 T-cell engagers - Market size and forecast 2024-2029
- Chart on T-cell engagers - Market size and forecast 2024-2029 ($ million)
- Data Table on T-cell engagers - Market size and forecast 2024-2029 ($ million)
- Chart on T-cell engagers - Year-over-year growth 2024-2029 (%)
- Data Table on T-cell engagers - Year-over-year growth 2024-2029 (%)
- 10.6 Market opportunity by Action Mechanism
- Market opportunity by Action Mechanism ($ million)
- Data Table on Market opportunity by Action Mechanism ($ million)
11 Market Segmentation by Therapeutic Area
- 11.1 Market segments
- Chart on Therapeutic Area - Market share 2024-2029 (%)
- Data Table on Therapeutic Area - Market share 2024-2029 (%)
- 11.2 Comparison by Therapeutic Area
- Chart on Comparison by Therapeutic Area
- Data Table on Comparison by Therapeutic Area
- 11.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
- 11.4 Autoimmune diseases - Market size and forecast 2024-2029
- Chart on Autoimmune diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Autoimmune diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Autoimmune diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Autoimmune diseases - Year-over-year growth 2024-2029 (%)
- 11.5 Infectious diseases - Market size and forecast 2024-2029
- Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
- 11.6 Neurological disorders - Market size and forecast 2024-2029
- Chart on Neurological disorders - Market size and forecast 2024-2029 ($ million)
- Data Table on Neurological disorders - Market size and forecast 2024-2029 ($ million)
- Chart on Neurological disorders - Year-over-year growth 2024-2029 (%)
- Data Table on Neurological disorders - Year-over-year growth 2024-2029 (%)
- 11.7 Market opportunity by Therapeutic Area
- Market opportunity by Therapeutic Area ($ million)
- Data Table on Market opportunity by Therapeutic Area ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 13.8 Ireland - Market size and forecast 2024-2029
- Chart on Ireland - Market size and forecast 2024-2029 ($ million)
- Data Table on Ireland - Market size and forecast 2024-2029 ($ million)
- Chart on Ireland - Year-over-year growth 2024-2029 (%)
- Data Table on Ireland - Year-over-year growth 2024-2029 (%)
- 13.9 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 13.10 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 13.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 13.12 Hungary - Market size and forecast 2024-2029
- Chart on Hungary - Market size and forecast 2024-2029 ($ million)
- Data Table on Hungary - Market size and forecast 2024-2029 ($ million)
- Chart on Hungary - Year-over-year growth 2024-2029 (%)
- Data Table on Hungary - Year-over-year growth 2024-2029 (%)
- 13.13 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 13.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 13.15 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 13.16 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 13.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
- 14.1 Market drivers
- 14.2 Market challenges
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 14.4 Market opportunities/restraints
15 Competitive Landscape
- 15.1 Overview
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.1 Companies profiled
- 16.2 Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 ABL Bio Inc.
- ABL Bio Inc. - Overview
- ABL Bio Inc. - Product / Service
- ABL Bio Inc. - Key offerings
- SWOT
- 16.5 AFFIMED N.V.
- AFFIMED N.V. - Overview
- AFFIMED N.V. - Product / Service
- AFFIMED N.V. - Key offerings
- SWOT
- 16.6 Akeso Inc.
- Akeso Inc. - Overview
- Akeso Inc. - Product / Service
- Akeso Inc. - Key offerings
- SWOT
- 16.7 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- 16.8 Aptevo Therapeutics Inc.
- Aptevo Therapeutics Inc. - Overview
- Aptevo Therapeutics Inc. - Product / Service
- Aptevo Therapeutics Inc. - Key offerings
- SWOT
- 16.9 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
- 16.10 Chugai Pharmaceutical Co. Ltd.
- Chugai Pharmaceutical Co. Ltd. - Overview
- Chugai Pharmaceutical Co. Ltd. - Product / Service
- Chugai Pharmaceutical Co. Ltd. - Key news
- Chugai Pharmaceutical Co. Ltd. - Key offerings
- SWOT
- 16.11 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- 16.12 EPIMAB BIOTHERAPEUTICS INC.
- EPIMAB BIOTHERAPEUTICS INC. - Overview
- EPIMAB BIOTHERAPEUTICS INC. - Product / Service
- EPIMAB BIOTHERAPEUTICS INC. - Key offerings
- SWOT
- 16.13 F STAR THERAPEUTICS INC.
- F STAR THERAPEUTICS INC. - Overview
- F STAR THERAPEUTICS INC. - Product / Service
- F STAR THERAPEUTICS INC. - Key offerings
- SWOT
- 16.14 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 16.15 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
- 16.16 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
- 16.17 Mereo BioPharma Group Plc
- Mereo BioPharma Group Plc - Overview
- Mereo BioPharma Group Plc - Product / Service
- Mereo BioPharma Group Plc - Key offerings
- SWOT
- 16.18 Merus N.V.
- Merus N.V. - Overview
- Merus N.V. - Product / Service
- Merus N.V. - Key offerings
- SWOT
17 Appendix
- 17.1 Scope of the report
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- 17.5 Data procurement
- 17.6 Data validation
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.8 Data synthesis
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
